After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as the world’s first transfemoral transcatheter mitral valve replacement ...

Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...

IRVINE, Calif., April 14, 2025--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the ...

Edwards Lifesciences has received Europe’s CE mark for its transcatheter mitral valve replacement system, Sapien M3, the company said Monday. The device is designed for people with symptomatic ...

The condition is more common in women and younger patients with valve disorder and can, in the worst case, lead to sudden cardiac arrest. Mitral annular disjunction, MAD, is a heart abnormality in ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

Its total funding is more than $200 million. Cardiac Dimensions is targeting a condition called mitral valve regurgitation, which involves the leakage of blood through the heart’s mitral valve ...

If you have severe tricuspid valve regurgitation, doctors may recommend repair or replacement surgery. The tricuspid valve is one of four valves in your heart’s four chambers. It’s on the ...

Transcatheter Mitral Valve Repair: Coronary Sinus Annuloplasty Devices Coronary sinus techniques for mitral repair have been conducted with disappointing results due to anatomical incongruities ...